2026-09-18T19:48:31Zhttps://dspace.mit.edu/server/oai/request

oai:dspace.mit.edu:1721.1/453572022-01-13T07:54:33Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023

Michael J. Cima. Li, Guang, M. Eng. Massachusetts Institute of Technology Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Massachusetts Institute of Technology. Department of Materials Science and Engineering 2009-04-29T17:30:07Z 2009-04-29T17:30:07Z 2008 2008 http://hdl.handle.net/1721.1/45357 316802620 Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2008. Includes bibliographical references (p. 45-48). There has been much hype in the research and development of continuous glucose monitoring technologies, driven by the enormous and rapidly expanding glucose monitoring market and the large and growing base of diabetes patients. Continuous glucose monitoring has shown significant benefits over traditional intermittent blood glucose testing in reducing the risks of developing long-term complications associated with diabetes, by maintaining blood glucose concentrations to near-normoglycemic levels and reducing glycemic variability. In this thesis, commercially available continuous glucose monitoring systems as well as those still in development are evaluated. SWOT analysis shows that continuous glucose monitoring has a promising future, but there remain a number of challenges to be overcome, such as accuracy, sensor span, data handling, cost and reimbursement issues. It is concluded that continuous glucose monitoring will be the roadmap for future diabetes management. Ongoing technological advances in continuous glucose monitoring systems will hopefully close the loop for a fully automated artificial pancreas and develop a cure for Type I diabetes. by Guang Li. M.Eng. 54 p. eng Massachusetts Institute of Technology M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 Materials Science and Engineering. Evaluation of continuous glucose monitoring systems Thesis application/pdf false Publication unknown unknown <Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="0413b906-2c7f-4b74-81e7-4514c4f3a57b"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Evaluation of continuous glucose monitoring systems</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2008</PublicationDate> <Authors> <Author> <DisplayName>Li, Guang, M. Eng. Massachusetts Institute of Technology</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Massachusetts Institute of Technology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>http://dspace.mit.edu/handle/1721.1/7582</License> <Keyword>Materials Science and Engineering.</Keyword> <Abstract>There has been much hype in the research and development of continuous glucose monitoring technologies, driven by the enormous and rapidly expanding glucose monitoring market and the large and growing base of diabetes patients. Continuous glucose monitoring has shown significant benefits over traditional intermittent blood glucose testing in reducing the risks of developing long-term complications associated with diabetes, by maintaining blood glucose concentrations to near-normoglycemic levels and reducing glycemic variability. In this thesis, commercially available continuous glucose monitoring systems as well as those still in development are evaluated. SWOT analysis shows that continuous glucose monitoring has a promising future, but there remain a number of challenges to be overcome, such as accuracy, sensor span, data handling, cost and reimbursement issues. It is concluded that continuous glucose monitoring will be the roadmap for future diabetes management. Ongoing technological advances in continuous glucose monitoring systems will hopefully close the loop for a fully automated artificial pancreas and develop a cure for Type I diabetes.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication>